scientists

Medical Affairs: Find the Missing KOLs

By Brian Castle Thought Leader Select is a company dedicated to one purpose:  helping companies in the life sciences to optimize their relationships with key opinion leaders in medicine. Biopharmaceutical, device, and diagnostics companies work with thought leaders in particular therapeutic areas and diseases as they develop and manufacture new treatment solutions for patients.  It’s …

Medical Affairs: Find the Missing KOLs Read More »

Throwing the Baby Out with the Bath Water: ACCME Bans Industry Scientists from CME

Industry Insights from Paul Meade, M. Sc, MPH A recent decision by the Accreditation Council for Continuing Medical Education to not allow scientists employed by pharmaceutical, diagnostics, and devices companies to give educational presentations to physicians at medical meetings has “stirred up a bee’s nest.” In other words, if you graduated from an accredited university, …

Throwing the Baby Out with the Bath Water: ACCME Bans Industry Scientists from CME Read More »

Italy's D3 Unites Pharmaceutical Industry, Academia for Public Health

A report in yesterday’s Pharma Letter illustrates how critical partnerships between the pharmaceutical industry and academia can be beneficial for patients, medical professionals and the pharmaceutical industry alike. The Italian Institute of Technology’s Drug Discovery and Development Unit (D3) “brings together scientists with experience in industry and academia to discover new drugs in pain, inflammation …

Italy's D3 Unites Pharmaceutical Industry, Academia for Public Health Read More »

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Four

Pharmaceutical & Biotechnology Companies Provide Early Knowledge-building Opportunities for KOLs and Clinical Investigators Understanding the value that key opinion leaders provide pharmaceutical and biotechnology companies is clear, but how do companies benefit thought leaders and clinical investigators? By definition, KOLs are physicians, scientists and academics who devote time to studying and advancing their craft. Often, …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Four Read More »